Analysts bullish on Apotex as they initiate coverage following Canadian drugmaker's IPO
Canadian generic drugmaker Apotex Health Corp.'s dominance could be leveraged into future higher-margin categories. Find out more
Probably going to sell CCJ
doubling down on energy